PMPaula Meneghetti

Paula Meneghetti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paula Meneghetti has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Characterization of Extracellular Vesicles from Attenuated and Virulent Leishmania amazonensis Promastigotes Reveals Distinct Proteomic Signatures

    by A. S. Vidal, E. da S. Duenha, Paula Meneghetti, RogérIa Cristina Zauli, Elizabeth Cristina PérEz, Ana Claudia Torrecilhas, A. F. A. Chaves, Solange M. T. Serrano, Wagner Luiz Batista, PatrícIa Xander

    Leishmaniasis is a group of endemic diseases caused by different species of Leishmania. Virulence factors produced by Leishmania can be found in extracellular vesicles (EVs), a heterogeneous group of particles released by cells that are involved in cell-to-cell communication. Herein, we demonstrated that Leishmania amazonensis subjected to three in vivo passages exhibited exacerbated virulence, while prolonged culture resulted in an attenuated profile. The morphological characterization of EVs released by these parasites showed no significant differences. However, proteomic analysis revealed enrichment of proteins associated with proteolysis in EVs released by virulent parasites. In addition, these EVs showed significantly higher proteasome activity compared to EVs from attenuated L. amazonensis promastigotes. Attenuated and virulent parasites incorporated EVs. However, we observed a significant increase in murine macrophage infectivity by virulent parasites following uptake of autologous EVs. Thus, our findings show that L. amazonensis parasites with distinct virulence profiles release EVs with differences in the relative abundance of their protein cargo, which may contribute to the maintenance or enhancement of parasite infectivity.

  • Trypanosoma Cruzi G and Y Strains' Metacyclic Trypomastigote Sheds Extracellular Vesicles and Trigger Host‐Cell Communication

    by Paula Meneghetti, Ewa Kozela, Daniel Alfandari, Paula Abou Karam, Ziv Porat, Patricia Xander, Neta Regev‐Rudzki, Sergio Schenkman, Ana Claudia Torrecilhas

    Trypanosoma cruzi, a protozoan parasite, spontaneously releases extracellular vesicles (EVs) that facilitate communication with both invertebrate and vertebrate hosts. The results obtained by several groups indicated compositional variations in EVs generated by distinct types of T. cruzi. Nonetheless, few studies have characterized EVs derived from metacyclic trypomastigotes (MT), the form that develops in the vector and infects vertebrate hosts. This study aimed to characterize and compare EVs extracted from MTs of two T. cruzi parasite strains belonging to distinct groups with varying infectivity patterns. We examined the nature of these EVs and their influence on parasite‐host interactions and host immune responses. Our findings demonstrated that EVs from G and Y strains showed no significant size differences; nonetheless, they exhibited variations in protein composition as shown by proteomic analysis, atomic force microscopy, and immunoenzymatic assays, including alterations in the presence of virulence factors. EVs from both strains interacted with and were taken up by human THP‐1 monocytes, resulting in NF‐κB activation. The EVs release from Y strain increase in the mRNA levels of RANTES, TNF‐alpha, and IFN‐beta, while inducing a similar nitric oxide (NO) increase relative to control cells. EVs from both strains also increased host cell invasion, however, EVs from the Y further increased the number of intracellular parasites. These results suggest that the infectivity of various strains by insect‐derived forms correlates with EV secretion via the control of the host immune response, potentially leading to distinct infection patterns.


  • Subcellular particles for characterization of host-parasite interactions

    by Ewa Kozela, Paula Meneghetti, Neta Regev-Rudzki, Ana Claudia Torrecilhas, Ziv Porat


  • Top Cited Papers
    Open Access

    Guidelines for the purification and characterization of extracellular vesicles of parasites

    by Carmen Fernandez‐Becerra, Patrícia Xander, Daniel Alfandari, George Dong, Iris Aparici‐Herraiz, Irit Rosenhek‐Goldian, Mehrdad Shokouhy, Melisa Gualdron‐Lopez, Nicholy Lozano, Nuria Cortes‐Serra, et al.

    Parasites are responsible for the most neglected tropical diseases, affecting over a billion people worldwide (WHO, 2015) and accounting for billions of cases a year and responsible for several millions of deaths. Research on extracellular vesicles (EVs) has increased in recent years and demonstrated that EVs shed by pathogenic parasites interact with host cells playing an important role in the parasite's survival, such as facilitation of infection, immunomodulation, parasite adaptation to the host environment and the transfer of drug resistance factors. Thus, EVs released by parasites mediate parasite‐parasite and parasite‐host intercellular communication. In addition, they are being explored as biomarkers of asymptomatic infections and disease prognosis after drug treatment. However, most current protocols used for the isolation, size determination, quantification and characterization of molecular cargo of EVs lack greater rigor, standardization, and adequate quality controls to certify the enrichment or purity of the ensuing bioproducts. We are now initiating major guidelines based on the evolution of collective knowledge in recent years. The main points covered in this position paper are methods for the isolation and molecular characterization of EVs obtained from parasite‐infected cell cultures, experimental animals, and patients. The guideline also includes a discussion of suggested protocols and functional assays in host cells


  • Isolation and molecular characterization of circulating extracellular vesicles from blood of chronic Chagas disease patients

    by Rafael P. Madeira, Paula Meneghetti, Lucas A. de Barros, Paula de Cassia Buck, Charles Mady, Barbara M. Ianni, Carmen Fernandez‐Becerra, Ana C. Torrecilhas

    Extracellular vesicles (EVs) are lipid bilayer envelopes that encase several types of molecules. Their contents mostly reflect their cell origin and possible targets at other locations in the organism and can be modified in pathological conditions to interfere with intercellular communication, thus promoting disease establishment and development. These characteristics, in addition to their presence in virtually all body fluids, make such vesicles ideal for biomarker discovery in human diseases. Here, we describe the effect of different anticoagulants and the combination of two purification methods for isolation and characterization of circulating EVs from blood of chronic Chagas disease (CCD) patients. We illustrated this procedure by studying a population of patients with Chagas disease at the indeterminate chronic stage, in which the Trypanosoma cruzi is very scarce in circulation. EVs were harvested from blood collected without or with different anticoagulants. Protein and nanoparticle tracking analysis was used to measure EVs size and concentration. The EVs were purified by ultracentrifugation, followed by size‐exclusion chromatography and characterized by chemiluminescent enzyme‐linked immunosorbent assay and dot blot using antibodies that recognized parasite‐derived EVs, such as hyperimmune sera, polyclonal and monoclonal antibodies against trans‐sialidase and mucins. In parallel, antibodies against classical human EV markers CD9, CD63, CD81, and CD82, were also analyzed. The results showed that anticoagulants did not interfere with the analyzed parameters and circulating EVs from CCD patients contain T. cruzi antigens and classical human exosomal markers. Overall, our protocol is adequate for the isolation of the total circulating EVs and can serve as an important basis for further studies on biomarker discovery in Chagas' disease.